HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical application of ET-Kyoto solution for lung transplantation.

Abstract
Because of the severe donor shortage in Japan, even after the revision of the Organ Transplant Law in 2010, the frequency of recovery of extended criteria lungs has increased in Japan. We developed a new lung preservation solution, "ET-Kyoto solution," to enhance lung preservation, to minimize primary graft dysfunction (PGD) and to improve the post-transplant outcomes. In this study, we retrospectively analyzed our results of lung transplantation using the ET-Kyoto solution. From 2002 to 2012, 26 patients underwent transplantation of lungs preserved with ET-Kyoto solution from brain-dead donors. We retrospectively reviewed the post-transplant pulmonary function and long-term survival. The graft performance was assessed by the PGD grading system. The mean graft ischemic time was 483.8 ± 19.0 min. The oxygenation capacity after reperfusion and recovery of respiratory function were both acceptable despite the long ischemic time. The survival rate at 5 years after transplantation was 85.1 %. Lungs preserved by ET-Kyoto solution had satisfactory postoperative lung function, despite the long preservation time, with excellent long-term survival. The results were acceptable for the use of grafts with a long ischemic time.
AuthorsMasaki Ikeda, Toru Bando, Tetsu Yamada, Masaaki Sato, Toshi Menjyu, Akihiro Aoyama, Toshihiko Sato, Fengshi Chen, Makoto Sonobe, Mitsugu Omasa, Hiroshi Date
JournalSurgery today (Surg Today) Vol. 45 Issue 4 Pg. 439-43 (Apr 2015) ISSN: 1436-2813 [Electronic] Japan
PMID24845738 (Publication Type: Journal Article)
Chemical References
  • Organ Preservation Solutions
Topics
  • Adolescent
  • Adult
  • Cold Ischemia
  • Graft Survival
  • Humans
  • Japan
  • Lung (blood supply, physiology)
  • Lung Transplantation (methods, mortality)
  • Male
  • Middle Aged
  • Organ Dysfunction Scores
  • Organ Preservation (methods)
  • Organ Preservation Solutions
  • Retrospective Studies
  • Survival Rate
  • Time Factors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: